Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Ly3537982
2. C2vj83psn7
3. Ly-3537982
4. Refchem:1093882
5. 2771246-13-8
6. Kras G12c Inhibitor 19
7. 2649788-46-3
8. 2-amino-4-[(4as)-8-chloro-10-fluoro-2,3,4,4a,5,6-hexahydro-12-oxo-3-(1-oxo-2-propen-1-yl)-1h,12h-pyrazino[2,1-d][1,5]benzoxazocin-9-yl]-7-fluorobenzo[b]thiophene-3-carbonitrile
9. 4-((s)-3-acryloyl-8-chloro-10-fluoro-12-oxo-2,3,4,4a,5,6-hexahydro-1h,12h-benzo[b]pyrazino[1,2-e][1,5]oxazocin-9-yl)-2-amino-7-fluorobenzo[b]thiophene-3-carbonitrile
10. Olomorasib [inn]
11. Orb1690700
12. Schembl23496727
13. Ex-a6653
14. Nsc853962
15. Akos040757943
16. Nsc-853962
17. Da-64768
18. Hy-132980
19. Cs-0311440
20. F78016
21. 2-amino-4-[(4as)-8-chloro-10-fluoro-2,3,4,4a,5,6-hexahydro-12-oxo-3-(1-oxo-2-propen-1-yl)-1h,12h-pyrazino[2,1-d][1,5]benzoxazocin-9-yl]-7-fluoro-benzo[b]thiophene-3-carbonitrile
22. 2-amino-4-[(4r)-8-chloro-10-fluoro-12-oxo-3-(prop-2-enoyl)-2,3,4,4a,5,6-hexahydro-1h,12h-pyrazino[2,1-d][1,5]benzoxazocin-9-yl]-7-fluoro-1-benzothiophene-3-carbonitrile
23. 4-[(13as)-10-chloro-8-fluoro-6-oxo-2-prop-2-enoyl-1,3,4,12,13,13a-hexahydropyrazino[2,1-d][1,5]benzoxazocin-9-yl]-2-amino-7-fluoro-1-benzothiophene-3-carbonitrile
24. Benzo[b]thiophene-3-carbonitrile, 2-amino-4-[(4as)-8-chloro-10-fluoro-2,3,4,4a,5,6-hexahydro-12-oxo-3-(1-oxo-2-propen-1-yl)-1h,12h-pyrazino[2,1-d][1,5]benzoxazocin-9-yl]-7-fluoro-, (4r)-
| Molecular Weight | 529.0 g/mol |
|---|---|
| Molecular Formula | C25H19ClF2N4O3S |
| XLogP3 | 4.8 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 2 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 128 |
| Heavy Atom Count | 36 |
| Formal Charge | 0 |
| Complexity | 952 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
12
PharmaCompass offers a list of Olomorasib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Olomorasib manufacturer or Olomorasib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Olomorasib manufacturer or Olomorasib supplier.
A Olomorasib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Olomorasib, including repackagers and relabelers. The FDA regulates Olomorasib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Olomorasib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Olomorasib supplier is an individual or a company that provides Olomorasib active pharmaceutical ingredient (API) or Olomorasib finished formulations upon request. The Olomorasib suppliers may include Olomorasib API manufacturers, exporters, distributors and traders.
Olomorasib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Olomorasib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Olomorasib GMP manufacturer or Olomorasib GMP API supplier for your needs.
A Olomorasib CoA (Certificate of Analysis) is a formal document that attests to Olomorasib's compliance with Olomorasib specifications and serves as a tool for batch-level quality control.
Olomorasib CoA mostly includes findings from lab analyses of a specific batch. For each Olomorasib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Olomorasib may be tested according to a variety of international standards, such as European Pharmacopoeia (Olomorasib EP), Olomorasib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Olomorasib USP).
